Clinical implications of autoantibody screening in patients with autoimmune myositis

@article{Ghirardello2006ClinicalIO,
  title={Clinical implications of autoantibody screening in patients with autoimmune myositis},
  author={Anna Ghirardello and Sandra Zampieri and Elena Tarricone and Luca Iaccarino and Raffaele Bendo and Chiara Briani and Riccardo Rondinone and P. Sarzi-Puttini and Silvano Todesco and Andrea Doria},
  journal={Autoimmunity},
  year={2006},
  volume={39},
  pages={217 - 221}
}
Objective: To evaluate the clinical usefulness of serum autoantibody profiling in patients with autoimmune myositis. Methods: We retrospectively studied 74 consecutive patients: 68 had definite or probable myositis according to Bohan–Peter criteria, six suffered from antisynthetase syndrome with subclinical myopathy. Myositis specific antibodies (MSA) (anti-ARS, -SRP, -Mi-2) were determined by RNA immunoprecipitation or immunoblot, myositis associated antibodies (MAA) (anti-RoRNP, -U1RNP, -PM… Expand
Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
TLDR
Anti-Ro-52 was correlation with pulmonary disorders in dermatomyositis, whereas anti-Jo-1 was correlated with pulmonary alterations in polymyositis and the data are consistent with those from other published studies involving other populations, although certain findings warrant consideration. Expand
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy
TLDR
Classic MSAs known for over 30 years include antibodies to Jo-1 and other aminoacyl tRNA synthetases (ARS), anti-Mi-2, and anti-signal recognition particle (SRP), and several new autoantibodies with strong clinical significance have been described in DM. Expand
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.
TLDR
Line blot could be a suitable serological test in the diagnostic workup for myositis, and it represents a reliable alternative to more time-consuming procedures. Expand
Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study
TLDR
Line immunoassays for myositis antibodies show high specificity but low sensitivity, which suggests that MSA/MAA should be used for confirmatory and differential diagnosis rather than for screening purposes in inflammatory myopathies. Expand
Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes
TLDR
It is concluded that a significant proportion of AIM patients are characterized by complex associations of autoantibodies, which are markers for distinct overlap syndromes and predict therapeutic outcomes. Expand
A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis
TLDR
A novel association of autoantibodies with DR4 and with arthralgia/synovitis in IIM is revealed and the possibility of a genetically (DR4) determined citrullination of myositis autoantigens expressed in muscle and synovium is raised. Expand
Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
TLDR
Except for anti-SSA/Ro-52 and anti-Ku the antibody reactivities were rather myositis-specific, supporting the use of this immunoblot assay, however, assay validation needs to be determined against other methods. Expand
Inflammatory Myopathies With Anti-Ku Antibodies: A Prognosis Dependent on Associated Lung Disease
TLDR
Investigation of the clinical, laboratory, and muscle histologic features of all anti-Ku-positive patients detected in the authors' hospital during the last 10 years found their presence can be frequently associated with corticosensitive IM and severe, corticoresistant ILD. Expand
Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
TLDR
Unlabelled protein immunoprecipitation is a specific analytical approach, appropriate for the identification of the recently described anti-SAE autoantibody, and the role of anti- SAE antibody as marker of dermatomyositis is confirmed. Expand
Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results
TLDR
The high specificity of a myositis LIA in a clinical setting was demonstrated, however, a significant burden of false positive results was evident in those with a low pre-test likelihood of IIM and for weakly positive autoantibodies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
[Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
TLDR
Serum MSA and/or MAA were found in 30/46 patients with IIM and anti-synthetase antibodies were closely associated with interstitial lung disease and polyarthritis; anti-Mi-2 positive DM patients did not have lung involvement. Expand
Clinical and serological characteristics of 125 Dutch myositis patients
TLDR
It can be concluded that MSAs define specific clinical syndromes within the spectrum of IIM and that they can assist in the differential diagnosis and treatment plan of these enigmatic disorders by virtually excluding IBM by their presence, and by potentially identifying a subgroup of steroid-responsive IBM patients. Expand
Autoantibody profiles in the sera of European patients with myositis
TLDR
The data show that some sera may contain more than one type of MSA and confirm the strong association of anti-Ro52 with anti-Jo-1 reactivity, which may be explained by the use of multiple recombinant fragments spanning the complete antigen. Expand
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
TLDR
Raynaud's phenomenon and muscular and joint involvement are the most frequent clinical features associated with anti-Ku antibodies, which are frequently detected in association withAnti-Ro/SSA and/or other antinuclear specificities. Expand
Update on myositis-specific and myositis-associated autoantibodies.
  • I. Targoff
  • Medicine
  • Current opinion in rheumatology
  • 2000
TLDR
New information about the cellular role of the antigens was discovered, including a role for Mi-2 antigen in chromosomally-mediated regulation of transcription as part of a nucleosome remodeling complex, and a potential role for PM-Scl antigen in ribosomal RNA processing as partof an exosome. Expand
A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups
TLDR
Myositis-specific autoantibody status is a more useful guide than clinical group in assessing patients with myositis, and that specific associations of immunogenetics, immune responses, and clinical manifestations occur in IIM. Expand
Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.
  • I. Targoff
  • Medicine
  • Rheumatic diseases clinics of North America
  • 2002
TLDR
The laboratory assessment of muscle-derived factors that reflect muscle injury, and the determination of serum autoantibodies, play valuable roles in the diagnosis and management of the IIM. Expand
Anti-Jo-1 Antibodies
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammatory myopathies (IIM). This antibody is directed against the histidyl-tRNA synthetaseExpand
Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies
TLDR
Screening of anti-ARS may be useful to predict late-onset myopathy in ILD-preceding patients and to predict the clinical course of ILD in PM/DM patients. Expand
Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies: Analysis of 100 French Canadian Patients
TLDR
The original Bohan and Peter classification should be abandoned as it leads to misclassification of patients, and the proposed modified and clinicoserologic classifications have diagnostic, prognostic, and therapeutic value. Expand
...
1
2
3
4
5
...